[1]张津生.肝硬化门静脉高压CT和磁共振成像的表现[J].医学信息,2021,34(14):57-59.[doi:10.3969/j.issn.1006-1959.2021.14.016]
　ZHANG Jin-sheng.CT and MRI Features of Portal Hypertension in Liver Cirrhosis[J].Medical Information,2021,34(14):57-59.[doi:10.3969/j.issn.1006-1959.2021.14.016]
点击复制

肝硬化门静脉高压CT和磁共振成像的表现()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年14期
页码:
57-59
栏目:
综述
出版日期:
2021-07-15

文章信息/Info

Title:
CT and MRI Features of Portal Hypertension in Liver Cirrhosis
文章编号:
1006-1959（2021）14-0057-03
作者:
张津生
（天津市宝坻区人民医院医学影像科，天津 301800）
Author(s):
ZHANG Jin-sheng
(Department of Medical Imaging,Tianjin Baodi Hospital,Tianjin 301800,China)
关键词:
肝硬化; 门静脉高压; CT; 磁共振成像
Keywords:
Liver cirrhosis; Portal hypertension; CT; Magnetic resonance imaging
分类号:
R445.2；R575.2
DOI:
10.3969/j.issn.1006-1959.2021.14.016
文献标志码:
A
摘要:
肝硬化门静脉高压症是肝硬化后期常见的一种综合征，食管胃底静脉曲张破裂出血是最严重并发症，也是上消化道出血是常见原因，病死率极高，严重威胁患者生命安全。早期诊断肝硬化门脉高压具有重要的意义。目前，无创影像学检查方法诊断肝硬化门静脉高压的重要手段，可清楚显示食管胃底静脉曲张和侧肢循环情况。而CT和磁共振成像（MRI）是常用的两种影响学检查手段。但是肝硬化门静脉高压CT和MRI的影像表现存在差异，具体显示情况不同。本文以下综述肝硬化门静脉高压CT和磁共振成像的表现特点，以期为肝硬化门静脉高压的诊断、病情评估以及预后的判断提供参考依据。
Abstract:
Liver cirrhosis and portal hypertension are a common syndrome in the late stage of liver cirrhosis.Bleeding from esophageal and gastric varices is the most serious complication, and it is also a common cause of upper gastrointestinal bleeding. The fatality rate is extremely high, which seriously threatens the life safety of patients.Early diagnosis of liver cirrhosis and portal hypertension is of great significance.At present, non-invasive imaging methods are an important method for the diagnosis of portal hypertension in liver cirrhosis, which can clearly show the esophagus and gastric varices and the circulation of the side limbs.CT and magnetic resonance imaging (MRI) are two commonly used methods of influencing studies. However, CT and MRI imaging manifestations of liver cirrhosis and portal hypertension are different, and the specific conditions are different.This article summarizes the characteristics of CT and magnetic resonance imaging of portal hypertension in liver cirrhosis, in order to provide a reference for the diagnosis, disease evaluation and prognostic judgment of portal hypertension in liver cirrhosis.

参考文献/References:

[1]王芳,沈加林,华静,等.能谱CT在预测肝硬化门脉高压食管静脉曲张出血风险的应用[J].放射学实践,2015,30(7):763-767. [2]孔祥,陈惠娟,罗松,等.肝硬化患者脑常规和扩散加权MR成像与门静脉高压测量参数的相关性[J].中华医学杂志,2014,94(32):2495-2500. [3]刘伟.彩色多普勒超声对老年肝硬化门静脉高压症的诊断价值[J].河北医学,2014,20(4):576-578. [4]李瑞雄,蒋仕伍,杨维珍,等.多层螺旋CT门静脉成像对肝硬化门脉高压侧支循环的诊断价值[J].中国临床新医学,2015,8(4):315-317. [5]梁萍,方华盛,陈更瑞,等.多层螺旋CT门静脉成像对门静脉高压症的诊断及分类价值[J].中国CT和MRI杂志,2015,13(2):47-49. [6]张建华,蒋微,农剑波,等.64排螺旋CT对门静脉高压症的诊断价值[J].中国CT和MRI杂志,2016,14(10):68-70. [7]吴琼.CTA对门脉高压症血管分流状态评估的初步研究[D].安徽医科大学,2015. [8]李瑞雄,杨维珍,蒋仕伍,等.MSCT静脉成像应用于肝硬化门脉高压症的诊断效果分析[J].医学影像学杂志,2016,26(9):1717-1719. [9]赵化岭.多层螺旋CT门静脉成像(MSCTP)对门脉高压侧支循环的评价[J].中外医疗,2014,34(8):178-179. [10]Loffroy R,Favelier S,Pottecher P,et al.Transcatheter arterial embo- lization for acute nonvariceal upper gastrointestinal bleeding:Indica- tions,techniques and outcomes[J].Diagn Interv Imaging,2015,96(7-8):731-744. [11]邢腾龙,成戈,周智鹏,等.MRI动态增强定量参数对肝细胞癌和肝良性肿瘤鉴别诊断的价值[J].实用放射学杂志,2016,32(3):366-369. [12]王红霞,张丽娟,刘正基,等.增强CT与胃镜检查对食管胃底静脉曲张的诊断价值对比观察[J].中国医学装备,2016,13(3):67-69. [13]刘桂勤,华静,沈加林,等.CT门静脉血管成像预测肝硬化门静脉高压食管胃底静脉曲张破裂出血价值[J].中华实用诊断与治疗杂志,2015,29(4):396-398. [14]王可,郭小超,王鹤,等.CT和MRI对乙肝肝硬化背景下肝细胞癌诊断评分的一致性:基于LI-RADS的多中心、个体内对照研究[J].放射学实践,2016,31(4):291-295. [15]穆雪纯,王宇,马红.肝硬化门静脉高压的无创评估[J].临床肝胆病杂志,2019,35(12):2796-2799. [16]Qiu S,Jiang B.Portal vein splenic venous hemodynamics doppler ultra- sonic features and clinical significance in patients with liver cirrhosis[J].Hebei Medicine,2015,21(2):192-195. [17]Copelan A,Chehab M,Dixit P,et al.Safety and efficacy of angio- graphic occlusion of duodenal varices as an alternative to TIPS:review of 32 cases[J].Ann Hepatol,2015,14(3):369-379. [18]王辉,于长路,韩宇欣,等.CT门静脉成像对门静脉高压食管胃底静脉曲张诊断的临床意义[J].国际医学放射学杂志,2017,40(3):249-253. [19]赵小林,孙雪艳.彩色多普勒超声对门静脉高压患者食管静脉曲张的评估意义[J].医学临床实践,2015,24(9):715-716. [20]戴细华,王楚铭.CT能谱成像技术诊断肝硬化门静脉高压并发EVB的价值[J].浙江临床医学,2016,18(7):1337-1338. [21]邱爽,姜波.肝硬化患者门静脉脾静脉血流动力学超声特点及临床意义[J].河北医学,2015,21(2):192-195. [22]汪仕友.多层螺旋CT在肝硬化门静脉高压静脉曲张及门体分流中的应用[J].中国现代普通外科进展,2015,18(5):392-393,396. [23]张元立,朱合伟.CT能谱成像在预测肝硬化门静脉高压并发食管静脉曲张破裂出血风险性中的价值[J].现代医用影像学,2017,26(6):1620-1622. [24]贺欢,孔文洁,高峰,等.295例食管静脉曲张病因及内镜下表现分析[J].实用肝脏病杂志,2017,20(5):550-553. [25]韩宇欣,于长路,王辉,等.双能量融合技术对肝门静脉成像质量的研究[J].实用放射学杂志,2017,33(5):769-772. [26]李勤涛,蒋力,张珂,等.无创模型预测肝炎肝硬化患者食管静脉曲张[J].中华肝脏病杂志,2015,23(5):339-342. [27]张嘉瑜,刘龙平,王成林,等.肝硬化门静脉高压侧支血管开放的影像学特征及临床意义[J].中国CT和MRI杂志,2016,14(1):77-80,122

相似文献/References:

[1]崔 洁.凝血酶原时间与血小板检验方式对诊断肝硬化疾病的临床价值研究[J].医学信息,2018,31(04):150.[doi:10.3969/j.issn.1006-1959.2018.04.055]
　CUI Jie.Study on the Clinical Value of Prothrombin Time and Platelet Examination in the Diagnosis of Liver Cirrhosis[J].Medical Information,2018,31(14):150.[doi:10.3969/j.issn.1006-1959.2018.04.055]
[2]张铁彪,刘建华,马长顺.肺癌肿瘤标记物结合胸部CT检查肺结节的定性分析[J].医学信息,2022,35(10):171.[doi:10.3969/j.issn.1006-1959.2022.10.044]
　ZHANG Tie-biao,LIU Jian-hua,MA Chang-shun.Qualitative Analysis of Lung Cancer Tumor Markers Combined with Chest CT Examination of Pulmonary Nodules[J].Medical Information,2022,35(14):171.[doi:10.3969/j.issn.1006-1959.2022.10.044]
[3]赵华莹,李运泽,韦天灵,等.肝硬化合并门静脉血栓形成的危险因素分析[J].医学信息,2019,32(03):86.[doi:10.3969/j.issn.1006-1959.2019.03.026]
　ZHAO Hua-ying,LI Yun-ze,WEI Tian-ling,et al.Analysis of Risk Factors for Cirrhotic Patients with Portal Vein Thrombosis[J].Medical Information,2019,32(14):86.[doi:10.3969/j.issn.1006-1959.2019.03.026]
[4]桂志兵,汪文生.红细胞分布宽度与血小板计数比值在乙型肝炎肝硬化患者病情评估中的作用[J].医学信息,2018,31(20):65.[doi:10.3969/j.issn.1006-1959.2018.20.019]
　GUI Zhi-bing,WANG Wen-sheng.The Role of Red Blood Cell Distribution Width and Platelet Ratio in the Evaluation of Patients with Hepatitis B Cirrhosis[J].Medical Information,2018,31(14):65.[doi:10.3969/j.issn.1006-1959.2018.20.019]
[5]王晓刚.利拉鲁肽联合胰岛素泵对2 型糖尿病合并肝硬化患者血糖代谢及肝纤维化的影响[J].医学信息,2018,31(20):136.[doi:10.3969/j.issn.1006-1959.2018.20.041]
　WANG Xiao-gang.Effects of Liraglutide Combined with Insulin Pump on Blood Glucose Metabolism and Liver Fibrosis in Patients with Type 2 Diabetes Mellitus Complicated with Cirrhosis[J].Medical Information,2018,31(14):136.[doi:10.3969/j.issn.1006-1959.2018.20.041]
[6]张宏程.生长抑素联合泮托拉唑治疗肝硬化合并上消化道出血的疗效观察[J].医学信息,2019,32(03):153.[doi:10.3969/j.issn.1006-1959.2019.03.050]
　ZHANG Hong-cheng.Therapeutic Effect of Somatostatin Combined with Pantoprazole on Hepatic Cirrhosis Complicated with Upper Gastrointestinal Hemorrhage[J].Medical Information,2019,32(14):153.[doi:10.3969/j.issn.1006-1959.2019.03.050]
[7]王翔翔,刘明忠,杨中秋,等.腹腔镜与开腹脾切除贲门周围血管离断术治疗肝硬化门静脉高压脾肿大的临床对比[J].医学信息,2019,32(01):109.[doi:10.3969/j.issn.1006-1959.2019.01.033]
　WANG Xiang-xiang,LIU Ming-zhong,YANG Zhong-qiu,et al.Clinical Comparison of Laparoscopic and Open Spleen Resection of the Pericardium in the Treatment of Cirrhosis with Portal Hypertension and Splenomegaly[J].Medical Information,2019,32(14):109.[doi:10.3969/j.issn.1006-1959.2019.01.033]
[8]姜海燕.双歧杆菌四联活菌治疗对肝硬化患者肝功能、细胞因子及肠道菌群的影响[J].医学信息,2022,35(12):156.[doi:10.3969/j.issn.1006-1959.2022.12.038]
　JIANG Hai-yan.Effect of Quadruple Viable Bifidobacterium Treatment on Liver Function, Cytokines and Intestinal Flora in Patients with Liver Cirrhosis[J].Medical Information,2022,35(14):156.[doi:10.3969/j.issn.1006-1959.2022.12.038]
[9]张许林,余泽波.肝硬化上消化道出血的输血治疗进展[J].医学信息,2019,32(08):85.[doi:10.3969/j.issn.1006-1959.2019.08.025]
　ZHANG Xu-lin,YU Ze-bo.Progress in Transfusion Therapy for Upper Gastrointestinal Hemorrhage[J].Medical Information,2019,32(14):85.[doi:10.3969/j.issn.1006-1959.2019.08.025]
[10]陈 杰.左旋肉碱治疗肝硬化并显性肝性脑病的效果观察[J].医学信息,2019,32(14):153.[doi:10.3969/j.issn.1006-1959.2019.14.051]
　CHEN Jie.Effect of L-carnitine on Liver Cirrhosis and Dominant Hepatic Encephalopathy[J].Medical Information,2019,32(14):153.[doi:10.3969/j.issn.1006-1959.2019.14.051]
[11]祁兴顺,周新苗,许向波,等.肝硬化患者应用特利加压素治疗期间发生 低钠血症的现状研究[J].医学信息,2018,31(09):1.[doi:10.3969/j.issn.1006-1959.2018.09.001]

更新日期/Last Update: 1900-01-01